drugset / Trial / NCT04320030

[18F]-DPA-714 PET/CT (Positron Emission Tomography/Computerized Tomography) in Triple Negative Breast Cancers

NCT04320030

NaSingle-groupOpen-labelDiagnostic

Summary

This phase II study is assessing the correlation between M1/M2 macrophage polarization determined by tumor immunohistochemistry analysis and \[18F\]DPA-714 PET/CT binding (qualitative and texture analysis) in patients with operable triple negative breast cancer.

Timeline

Start
2020-06-11
Primary completion
2021-07-21
Completion
2021-07-21

Drugs

EvaluationDrugModalityDoseRoute
Subject [18F]DPA-714 Diagnostic / imaging agent 3 mbq/kg Intravenous